SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001501134-23-000117
Filing Date
2023-12-14
Accepted
2023-12-14 16:29:26
Documents
14
Period of Report
2023-12-13
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nvta-20231213.htm   iXBRL 8-K 29869
2 EX-99.1 a20231213-pressrelease.htm EX-99.1 12588
6 nvta-20231213_g1.jpg GRAPHIC 36208
  Complete submission text file 0001501134-23-000117.txt   264324

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nvta-20231213.xsd EX-101.SCH 1901
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nvta-20231213_lab.xml EX-101.LAB 23834
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nvta-20231213_pre.xml EX-101.PRE 12508
8 EXTRACTED XBRL INSTANCE DOCUMENT nvta-20231213_htm.xml XML 2713
Mailing Address 1400 16TH STREET SAN FRANCISCO CA 94103
Business Address 1400 16TH STREET SAN FRANCISCO CA 94103 (415) 374-7782
Invitae Corp (Filer) CIK: 0001501134 (see all company filings)

IRS No.: 271701898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36847 | Film No.: 231487412
SIC: 8071 Services-Medical Laboratories